The University of Cambridge is launching its second enterprise fund for the 2013-14 tax year to support the University’s commercialisation efforts with the target of raising £1.5m ($2.2m).
The first fund made three investments (Cambridge CMOS Sensors, DefiniGEN, and Inotec AMD) during November last year. Then last month, it took part in a $2.5m series A for Sphere Fluidics, a Cambridge life sciences spin-out, led by private equity firm 24Haymarket with participation from the Royal Society and a number of others. Cambridge expects the first fund to be fully invested within the coming months.
The University has produced 12 companies valued at over $1bn, two of which, microprocessor manufacturer ARM and HP-owned software firm Autonomy, are valued in excess of $10bn. Most of the companies are either founded through tech transfer activity, or by Cambridge graduates.
“The response from University alumni and friends to…
